Chinese ADR Delisting Risk: What the HFCAA Means for Investors

The single most-asked question about US-listed Chinese stocks is some version of: "Could my shares just get delisted?" The honest answer is that it's a real, recurring risk rooted in a long-running audit dispute — but a delisting wouldn't make your shares worthless overnight. Here's what's actually going on.

The root issue: audit inspections

US law requires that the Public Company Accounting Oversight Board (PCAOB) be able to inspect the auditors of any company listed on a US exchange. For years, China blocked inspection of mainland- and Hong Kong–based auditors on national-security grounds. That standoff is the heart of the matter.

What the HFCAA does

The Holding Foreign Companies Accountable Act (HFCAA), passed in 2020, says that if the PCAOB cannot inspect a company's auditor for three consecutive years, the SEC must remove that company from US exchanges. It put a concrete countdown on the audit dispute.

Where things stand now

In August 2022, the China Securities Regulatory Commission and the PCAOB reached an agreement giving inspectors access, and the PCAOB reported it had completed inspections by December 2022 — which paused the delisting clock. However, that arrangement can be revoked, and the underlying legal conflict was never resolved legislatively.

The risk has resurfaced since: in early 2025 a US "America First Investment Policy" memo signalled renewed scrutiny of Chinese listings and the possibility of tougher enforcement. As of recent reporting, several hundred Chinese companies remain US-listed with a combined value above a trillion dollars — so this is a live policy question, not a settled one. Treat the specifics as a moving target and check current news before acting.

What actually happens if a company is delisted?

A US delisting removes the shares from the NYSE/NASDAQ — it does not cancel your ownership. In practice, for Chinese companies the common outcomes are:

• Convert to the Hong Kong listing. Many large Chinese ADRs now also trade in Hong Kong, and brokers have increasingly let holders convert ADRs into the Hong Kong shares. This is the single biggest reason a dual listing matters.
• Trade over-the-counter (OTC). Delisted ADRs often continue trading OTC, though typically with worse liquidity and wider spreads.
• Forced sale / cash-out in some scenarios, depending on the company and your broker.

How investors manage the risk

• Favour companies with a Hong Kong listing, which gives a fallback venue. See ADR vs H-share vs A-share.
• Buy the Hong Kong line directly if your broker allows it, sidestepping the US mechanism entirely.
• Size positions for the policy risk, not just the business — and stay aware of current US–China headlines.

Frequently asked questions

Would I lose all my money if a Chinese ADR is delisted?

Not automatically. Delisting changes where and how easily the shares trade; it doesn't erase the underlying economic interest. The biggest practical risks are reduced liquidity and the friction of converting or moving to another venue.

Which Chinese ADRs are safest from delisting?

No ADR is immune, but companies with an established Hong Kong listing have a clear fallback. You can identify Hong Kong–listed Chinese companies in the screener by filtering for the Hong Kong region.

Is this risk priced in already?

Markets repeatedly reprice Chinese ADRs as the policy outlook shifts, so much of the risk is reflected in valuations at any given moment — but the outcome is binary and headline-driven, which is why it stays volatile.